RxAll
New Haven, US · Founded 2016 · Delaware corporation · 5 known investors
RxAll uses testing technology to detect counterfeit and substandard medicines, helping healthcare companies, pharmacies, and patients access verified high-quality drugs. It also offers financing and sales software for pharmacies and wholesalers, with a focus on Africa.
Founders & leadership
RxAll was founded in 2016 by Adebayo Alonge and Amy Kao.
Board
DT
Investors · 5
Reported raises · per SEC filings
Form D private placements$2M disclosed across 1 round · 2021
▶$2MraisedJun 2021 · 13 investors · OtherRule 506(b)
▶$2MraisedJun 2021 · 13 investors · Other
Rule 506(b)Officers, directors & promoters on the filing
- Adebayo AlongeExecutive Officer, Director
- Duncan TurnerDirector
- Amy KaoDirector
- Offering amount
- $3M
- Amount sold
- $2M
- First sale
- Apr 2021
- Incorporated
- Corporation, Delaware, 2016
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Competitors · 1
by search overlapCompanies competing with RxAll for the same Google search keywords, organic and paid, via search-intersection analysis.
In the news
Frequently asked questions
- What does RxAll do?
- RxAll uses testing technology to detect counterfeit and substandard medicines, helping healthcare companies, pharmacies, and patients access verified high-quality drugs. It also offers financing and sales software for pharmacies and wholesalers, with a focus on Africa.
- Who founded RxAll?
- RxAll was founded by Adebayo Alonge, Amy Kao in 2016.
- Who are RxAll's investors?
- RxAll's investors include Founders Factory Africa, LoftyInc Capital, SOSV, HAX, Launch Africa Ventures.
- How much funding has RxAll raised?
- RxAll has disclosed $2M raised across 1 round.
- Where is RxAll headquartered?
- RxAll is headquartered in New Haven, US.

